Suchergebnisse - "2494G1JF75"

PubPharm (718)

1

Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV

enthalten in: The Pediatric infectious disease journal | 2023

von Chabala, C. | Turkova, A. | Kapasa, M. | +113

2

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children : A Substudy of the CHAPAS-4 Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Waalewijn, H. | Szubert, A. | Wasmann, R. | +18

3

Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Abdizadeh, R. | Hadizadeh, F. | Abdizadeh, T.

4

Pharmacokinetics, Safety, and Bioequivalence of 2 Lopinavir/Ritonavir (200/50 mg) Tablets in Healthy Chinese Volunteers : Effect of Food on Absorption

enthalten in: Clinical pharmacology in drug development | 2023

von Zhang, W. | Lin, L. | Fu, W. | +5

5

Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus

enthalten in: The Cochrane database of systematic reviews | 2023

von Ugwu, E. | Eleje, G. | Ugwu, A. | +4

6

Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis

enthalten in: AIDS research and human retroviruses | 2023

von Leal, L. | Guardo, A. | Bedoya, L. | +10

7

Brief Report : Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Jacobs, T. | Mumbiro, V. | Chitsamatanga, M. | +48

8

Implications of the Digestion of Milk-Based Formulations for the Solubilization of Lopinavir/Ritonavir in a Combination Therapy

enthalten in: Molecular pharmaceutics | 2023

von Salim, M. | Ramirez, G. | Clulow, A. | +2

9

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial

enthalten in: Influenza and other respiratory viruses | 2023

von Alotaibi, F. | Alharbi, N. | Rosen, L. | +25

10

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

enthalten in: JAMA | 2023

von Writing Committee for the REMAP-CAP Investigators | Higgins, A. | Berry, L. | +164

CommentIn: JAMA. 2023 Jan 3;329(1):25-27. - PMID 36525259

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[72]